Cepheid, now part of Danaher Corporation, was a molecular diagnostics company that developed and manufactured systems for testing infectious diseases and other medical conditions. The company was founded in 1996 and went public in 2000.
Cepheid's main product was the GeneXpert system, which used polymerase chain reaction (PCR) technology to detect various diseases, including tuberculosis, HIV, and MRSA, among others. The GeneXpert system was considered a game-changer in the field of molecular diagnostics due to its speed, accuracy, and ease of use.
In September 2016, Danaher Corporation acquired Cepheid for approximately $4 billion, and the company became part of Danaher's diagnostics platform. Today, Cepheid's products and technologies are still being used in the fight against infectious diseases around the world.
|
